94,092 results on '"SECURITIES LAW"'
Search Results
2. Xtl Biopharmaceuticals Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 30, 2024)
3. Vivos Therapeutics, Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Dec. 26, 2024)
4. Protagenic Therapeutics, Inc. Files SEC Form 424B3, Prospectus [Rule 424(B)(3)]: (Dec. 27, 2024)
5. Palvella Therapeutics, Inc. Files SEC Form S-1, General Form For Registration of Securities Under The Securities Act of 1933: (Dec. 31, 2024)
6. Northwest Biotherapeutics Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Dec. 26, 2024)
7. Kazia Therapeutics Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 31, 2024)
8. Kazia Therapeutics Ltd Files SEC Form 424B3, Prospectus [Rule 424(B)(3)]: (Dec. 31, 2024)
9. Can-fite Biopharma Ltd. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 30, 2024)
10. Alterity Therapeutics Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 31, 2024)
11. Aclaris Therapeutics, Inc. Files SEC Form 424B3, Prospectus [Rule 424(B)(3)]: (Dec. 31, 2024)
12. Zyversa Therapeutics, Inc. Files SEC Form S-3, Registration Statement Under Securities Act of 1933: (Dec. 20, 2024)
13. Xortx Therapeutics Inc. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 19, 2024)
14. Quantum Biopharma Ltd. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 20, 2024)
15. Protagenic Therapeutics, Inc. Files SEC Form S-1, General Form For Registration of Securities Under The Securities Act of 1933: (Dec. 20, 2024)
16. Phio Pharmaceuticals Corp. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Dec. 23, 2024)
17. Phio Pharmaceuticals Corp. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Dec. 20, 2024)
18. Nok Therapeutics, Inc. Files SEC Form 1-A/A, Offering Statement [Regulation A]: (Dec. 23, 2024)
19. Neurosense Therapeutics Ltd. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 23, 2024)
20. Monopar Therapeutics Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Dec. 23, 2024)
21. Lakeshore Biopharma Co., Ltd. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 19, 2024)
22. Indaptus Therapeutics, Inc. Files SEC Form S-1, General Form For Registration of Securities Under The Securities Act of 1933: (Dec. 23, 2024)
23. Gt Biopharma, Inc. Files SEC Form S-1, General Form For Registration of Securities Under The Securities Act of 1933: (Dec. 23, 2024)
24. Cosciens Biopharma Inc. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 23, 2024)
25. Connect Biopharma Holdings Ltd Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 23, 2024)
26. Cadrenal Therapeutics, Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Dec. 20, 2024)
27. Aptevo Therapeutics Inc. Files SEC Form S-3, Registration Statement Under Securities Act of 1933: (Dec. 20, 2024)
28. Altamira Therapeutics Ltd. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 20, 2024)
29. Aclaris Therapeutics, Inc. Files SEC Form S-3, Registration Statement Under Securities Act of 1933: (Dec. 19, 2024)
30. Xortx Therapeutics Inc. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 12, 2024)
31. Xortx Therapeutics Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Dec. 13, 2024)
32. Trevi Therapeutics, Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Dec. 16, 2024)
33. Taysha Gene Therapies, Inc. Files SEC Form S-3, Registration Statement Under Securities Act of 1933: (Dec. 13, 2024)
34. Relief Therapeutics Holding Sa Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 16, 2024)
35. Relief Therapeutics Holding Sa Files SEC Form 424B3, Prospectus [Rule 424(B)(3)]: (Dec. 17, 2024)
36. Nok Therapeutics, Inc. Files SEC Form 1-A/A, Offering Statement [Regulation A]: (Dec. 17, 2024)
37. Neurosense Therapeutics Ltd. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 17, 2024)
38. Neurosense Therapeutics Ltd. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 18, 2024)
39. Neurosense Therapeutics Ltd. Files SEC Form 424B3, Prospectus [Rule 424(B)(3)]: (Dec. 12, 2024)
40. Monopar Therapeutics Files SEC Form 424B3, Prospectus [Rule 424(B)(3)]: (Dec. 18, 2024)
41. Lakeshore Biopharma Co., Ltd. Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 12, 2024)
42. Cartesian Therapeutics, Inc. Files SEC Form S-3, Registration Statement Under Securities Act of 1933: (Dec. 13, 2024)
43. Calidi Biotherapeutics, Inc. Files SEC Form S-1, General Form For Registration of Securities Under The Securities Act of 1933: (Dec. 12, 2024)
44. Briacell Therapeutics Corp. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Dec. 12, 2024)
45. Ascendis Pharma A Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 17, 2024)
46. Ascendis Pharma A Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 12, 2024)
47. Transcode Therapeutics, Inc. Files SEC Form S-1, General Form For Registration of Securities Under The Securities Act of 1933: (Dec. 6, 2024)
48. Sonnet Biotherapeutics Holdings, Inc. Files SEC Form 424B5, Prospectus [Rule 424(B)(5)]: (Dec. 10, 2024)
49. Silence Therapeutics Plc Files SEC Form 6-K, Report of Foreign Issuer [Rules 13A-16 And 15D-16]: (Dec. 9, 2024)
50. Regen Biopharma Inc. Files SEC Form QUALIF, Notice of Qualification [Regulation A]: (Dec. 10, 2024)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.